Pricing Log in Create free account

Sangamo Therapeutics, Inc. (SGMOQ) vs Instil Bio, Inc. (TIL)

Sangamo Therapeutics, Inc. and Instil Bio, Inc. are both Biotechnology companies. Sangamo Therapeutics, Inc. and Instil Bio, Inc. are of similar size ($41.9M and $41.6M). Instil Bio, Inc. has the higher net margin (0.00% vs −356.9%) and the lower return on invested capital (−18.9% vs 0.00%). Across the 15 metrics below, Instil Bio, Inc. leads on 8 and Sangamo Therapeutics, Inc. on 7.

Valuation

Metric SGMOQ TIL Biotechnology median
P/E n/m n/m 8.50
P/S 1.24 290.45 9.71
P/B n/m 0.37 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.24 401.03 9.21
Earnings yield (345.45%) (75.63%) (33.15%)
Free cash flow yield (211.06%) (110.46%) (25.50%)

Profitability

Metric SGMOQ TIL Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (357.55%) 0.00% 0.00%
Net margin (356.89%) 0.00% 0.00%
Free cash flow margin (261.76%) 0.00% 0.00%
Return on equity 1,755.72% (25.33%) (56.36%)
Return on assets (168.79%) (14.13%) (48.04%)
Return on invested capital 0.00% (18.94%) 0.00%

Growth

Metric SGMOQ TIL Biotechnology median
Revenue growth (TTM) (45.80%) — 6.02%
EPS growth (last fiscal year) 10.20% 6.06% 30.26%
Revenue growth, 5-year CAGR (19.66%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SGMOQ TIL Biotechnology median
Debt to equity 0.00 0.79 0.00
Current ratio 0.70 21.67 4.72
Net debt to EBITDA 0.18 (0.11) 0.96

Dividend

Metric SGMOQ TIL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SGMOQ TIL Biotechnology median
Market cap 41.89m 41.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack